Illumina in Discussions To Reacquire GRAIL; Cancer Diagnostic Company Was Spun Out in 2016 Bloomberg reports that, rather than going public, GRAIL is in talks to be acquired by Illumina, which spun out the company in 2016. 2 MIN READ 09.16.2020
Thermo Fisher Agrees To Buy Genetic Tester Qiagen in $11.5 Billion Deal Qiagen is one of the world’s largest suppliers of products to prepare tissue and blood samples for advanced testing. 3 MIN READ 03.3.2020
Illumina and Pacific Biosciences Terminate Merger After FTC Challenge The transaction would have valued PacBio at $1.2 billion. 3 MIN READ 01.3.2020
The #1 Reason the World’s Most Powerful Stock Is Crashing Why are so many formerly powerful “Big Oil” stocks trading like they’re going out of business? 6 MIN READ 11.5.2019
Walmart Is Quietly Turning Healthcare on Its Head The retail giant is disrupting America's most broken industry. 5 MIN READ 10.2.2019
Robotics and AI: How to Invest in the Promise of a Longer Life Robotics and artificial intelligence are setting the stage for longer lifespans and new investment opportunities. 5 MIN READ 05.17.2019
